About Cellworks
Cellworks is a company based in San Jose (United States) founded in 2005.. Cellworks has raised $16.52 million across 2 funding rounds. Cellworks operates in a competitive market with competitors including Genuity Science, ICarbonX, Rhelixa, Geneyx and Codetta, among others.
- Headquarter San Jose, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$2.59 M (USD)4as on Mar 31, 2023
-
Net Profit
$267.69 K (USD)-36as on Mar 31, 2023
-
EBITDA
$430.7 K (USD)-24as on Mar 31, 2023
-
Total Equity Funding
$16.52 M (USD)
in 2 rounds
-
Latest Funding Round
$13 M (USD), Series B
Dec 26, 2012
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Cellworks
Cellworks has successfully raised a total of $16.52M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $13 million completed in December 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $13.0M
-
First Round
First Round
(16 Apr 2009)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2012 | Amount | Series B - Cellworks | Valuation |
investors |
|
| Apr, 2009 | Amount | Series A - Cellworks | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Cellworks
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cellworks
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cellworks Comparisons
Competitors of Cellworks
Cellworks operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Genuity Science, ICarbonX, Rhelixa, Geneyx and Codetta, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based omics data analysis solutions are provided to researchers.
|
|
| domain | founded_year | HQ Location |
Bioinformatics platforms are provided for health management and drug development.
|
|
| domain | founded_year | HQ Location |
Integrated genomic analysis platform for epigenome data is provided.
|
|
| domain | founded_year | HQ Location |
Provider of a clinical genetics data management platform for hospitals and genetic labs
|
|
| domain | founded_year | HQ Location |
Omics clinical data is analyzed through an online platform.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cellworks
Frequently Asked Questions about Cellworks
When was Cellworks founded?
Cellworks was founded in 2005 and raised its 1st funding round 4 years after it was founded.
Where is Cellworks located?
Cellworks is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Is Cellworks a funded company?
Cellworks is a funded company, having raised a total of $16.52M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.52M, raised on Apr 16, 2009.
What is the annual revenue of Cellworks?
Annual revenue of Cellworks is $2.59M as on Mar 31, 2023.
What does Cellworks do?
Founded in 2005 and based in San Jose, United States, Cellworks operates in the biotechnology sector. A biosimulation platform is provided to the life science industry, utilizing computational modeling to create frameworks for therapeutic development. Responses to FDA-approved cancer therapies are predicted, and personalized cancer therapy recommendations are offered through this platform.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.